Page last updated: 2024-11-04

temozolomide and Hypopigmentation

temozolomide has been researched along with Hypopigmentation in 1 studies

Hypopigmentation: A condition caused by a deficiency or a loss of melanin pigmentation in the epidermis, also known as hypomelanosis. Hypopigmentation can be localized or generalized, and may result from genetic defects, trauma, inflammation, or infections.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Karakis, I1
McGeeney, B1
Demierre, MF1
Thiele, JJ1
Wolpowitz, D1
Bhawan, J1

Other Studies

1 other study available for temozolomide and Hypopigmentation

ArticleYear
Acquired hypopigmentation (leukoderma) as a presenting feature of metastatic amelanotic melanoma with brain involvement.
    Archives of neurology, 2007, Volume: 64, Issue:12

    Topics: Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Brain; Brain Neoplasms; Dacarbazine; De

2007